BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Warner Bros
WBD
|
+$2.81B |
| 2 |
Linde
LIN
|
+$2.35B |
| 3 |
Chevron
CVX
|
+$1.53B |
| 4 |
Pfizer
PFE
|
+$1.38B |
| 5 |
UnitedHealth
UNH
|
+$1.35B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AT&T
T
|
+$3.75B |
| 2 |
CERN
Cerner Corp
CERN
|
+$2.23B |
| 3 |
AZPN
ASPEN TECHNOLOGY INC
AZPN
|
+$1.1B |
| 4 |
Baidu
BIDU
|
+$1.07B |
| 5 |
NXP Semiconductors
NXPI
|
+$998M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.26% |
| 2 | Healthcare | 15.23% |
| 3 | Financials | 12.33% |
| 4 | Consumer Discretionary | 9.59% |
| 5 | Industrials | 8.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LYRA
4751
DELISTED
LYRA THERAPEUTICS INC
LYRA
| $235K | ﹤0.01% |
832
+452
| +119% | +$123K |
|
4752
Cellectar Biosciences
CLRB
$20.5M
| $232K | ﹤0.01% |
1,915
-461
| -19% | -$65.8K |
|
|
SCX
4753
DELISTED
The L.S. Starrett Company
SCX
| $232K | ﹤0.01% |
33,047
+608
| +2% | +$4.41K |
|
|
CALA
4754
DELISTED
Calithera Biosciences, Inc
CALA
| $231K | ﹤0.01% |
93,391
-2,909
| -3% | -$13.5K |
|
|
OLOX
4755
Olenox Industries
OLOX
$6.74M
| $230K | ﹤0.01% |
23
| – | – |
|
|
CIZN
4756
DELISTED
Citizens Holding Co.
CIZN
| $230K | ﹤0.01% |
12,761
-1,008
| -7% | -$18.5K |
|
|
ZH
4757
Zhihu
ZH
$281M
| $229K | ﹤0.01% |
21,263
-3,326
| -14% | -$35.8K |
|
|
LABP
4758
DELISTED
Landos Biopharma, Inc. Common Stock
LABP
| $229K | ﹤0.01% |
31,474
-20,557
| -40% | -$187K |
|
|
SDIG
4759
DELISTED
Stronghold Digital Mining, Inc. Class A Common Stock
SDIG
| $227K | ﹤0.01% |
13,695
-29,870
| -69% | -$948K |
|
4760
HireQuest
HQI
$180M
| $221K | ﹤0.01% |
15,686
-225,144
| -93% | -$3.53M |
|
|
ACCS
4761
ACCESS Newswire
ACCS
$25.6M
| $221K | ﹤0.01% |
8,713
-2,522
| -22% | -$62.3K |
|
4762
CervoMed
CRVO
$23.9M
| $219K | ﹤0.01% |
21,901
-2
| -0% | -$25 |
|
4763
MIND Technology
MIND
$45.3M
| $219K | ﹤0.01% |
24,690
-3,283
| -12% | -$34.2K |
|
4764
Pampa Energía
PAM
$4.75B
| $218K | ﹤0.01% |
10,638
-4,480
| -30% | -$99.2K |
|
4765
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
$45.8B
| $217K | ﹤0.01% |
704
-21
| -3% | -$6.87K |
|
4766
First Trust NASDAQ-100 Technology Index Fund
QTEC
$4.52B
| $216K | ﹤0.01% |
1,891
| – | – |
|
|
ASPU
4767
DELISTED
ASPEN GROUP, INC.
ASPU
| $213K | ﹤0.01% |
216,518
-56,036
| -21% | -$54.6K |
|
4768
Riskified
RSKD
$694M
| $212K | ﹤0.01% |
47,707
-323,589
| -87% | -$1.68M |
|
4769
Zedge
ZDGE
$38.6M
| $212K | ﹤0.01% |
73,559
-3,544
| -5% | -$17.5K |
|
4770
GH Research
GHRS
$1.93B
| $210K | ﹤0.01% |
21,086
+4,196
| +25% | +$54.5K |
|
|
PTRS
4771
DELISTED
Partners Bancorp Common Stock
PTRS
| $210K | ﹤0.01% |
23,149
-3,148
| -12% | -$28.4K |
|
|
SFBC
4772
Sound Financial Bancorp
SFBC
$112M
| $208K | ﹤0.01% |
5,454
-613
| -10% | -$22.9K |
|
4773
Biofrontera
BFRI
$15M
| $206K | ﹤0.01% |
5,538
+513
| +10% | +$31.1K |
|
4774
CareCloud
CCLD
$104M
| $206K | ﹤0.01% |
60,056
+467
| +0.8% | +$1.85K |
|
4775
Affinity Bancshares
AFBI
$140M
| $204K | ﹤0.01% |
13,768
-4,275
| -24% | -$63.8K |
|
Similar funds
BlackRock's Q2 2022 Portfolio in Review
As of Q2 2022, BlackRock held 6,138 positions worth $3.12T, down 16% from $3.71T the previous quarter. Its ten largest holdings account for 19% of the portfolio.
BlackRock's Q2 2022 filing shows 278 new, 2,738 increased, 2,355 reduced and 221 closed positions. Its largest new stake was Aspen Technology Inc: 2,824,931 shares worth $519M. The largest sale was AT&T, an estimated $3.75B.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.
- BlackRock's largest Q2 2022 buy was Aspen Technology Inc: 2,824,931 shares worth $519M.
- BlackRock added most to Warner Bros in Q2 2022, an estimated $2.81B increase.
- BlackRock's biggest Q2 2022 reduction was AT&T, cutting an estimated $3.75B.
- BlackRock fully exited Cerner Corp in Q2 2022, selling an estimated $2.23B.
- BlackRock's ten largest holdings make up 19% of its $3.12T portfolio in Q2 2022.
- BlackRock opened 278 new positions and closed 221 in Q2 2022.
- BlackRock's portfolio value fell 16% quarter-over-quarter to $3.12T.
Based on BlackRock's 13F filing for Q2 2022, filed 12 Aug 2022.